Clinical Trials Browser

Phase 2 × Withdrawn × dehydroftorafur × Clear all

NCT04481204 2026-05-04

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Phase 2 Withdrawn

Gastrointestinal

Borderline Resectable Pancreatic Adenocarcinoma